Sale!

ALL PCR Panel Cytogenetics – BCR/ABL, TEL/AML1, MLL, E2A

Original price was: $376.Current price is: $276.

-27%

The ALL PCR Panel Cytogenetics test is a comprehensive genetic analysis that detects specific chromosomal abnormalities associated with Acute Lymphoblastic Leukemia (ALL). This advanced diagnostic tool identifies BCR/ABL, TEL/AML1, MLL, and E2A gene rearrangements using Real-Time PCR technology, providing crucial information for accurate diagnosis, prognosis assessment, and treatment monitoring. The test requires bone marrow or peripheral blood samples and delivers results within 5-6 days. Available for only $276 USD, this specialized genetic panel helps healthcare providers develop targeted treatment strategies and monitor disease progression in leukemia patients.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ALL PCR Panel Cytogenetics – BCR/ABL, TEL/AML1, MLL, E2A

Comprehensive Genetic Analysis for Leukemia Diagnosis

The ALL PCR Panel Cytogenetics test represents a cutting-edge molecular diagnostic approach specifically designed for the comprehensive evaluation of Acute Lymphoblastic Leukemia (ALL). This sophisticated genetic panel utilizes Real-Time PCR technology to detect and quantify specific chromosomal abnormalities that play critical roles in leukemia development and progression. By analyzing BCR/ABL, TEL/AML1, MLL, and E2A gene rearrangements, this test provides invaluable insights for accurate diagnosis, prognosis assessment, and treatment monitoring.

What This Advanced Genetic Test Measures

Our ALL PCR Panel Cytogenetics test precisely detects and analyzes four key genetic markers:

  • BCR/ABL Fusion Gene: Identifies the Philadelphia chromosome translocation, a critical prognostic indicator in ALL
  • TEL/AML1 Rearrangement: Detects the t(12;21) translocation associated with favorable prognosis in pediatric ALL
  • MLL Gene Rearrangements: Screens for mixed-lineage leukemia gene abnormalities linked to aggressive disease forms
  • E2A-PBX1 Fusion: Identifies the t(1;19) translocation with specific treatment implications

Who Should Consider This Genetic Testing

This comprehensive genetic panel is recommended for individuals presenting with:

  • Unexplained fatigue, weakness, or persistent fever
  • Frequent infections and compromised immune function
  • Unexplained bruising, bleeding, or petechiae
  • Bone pain or joint discomfort
  • Enlarged lymph nodes, spleen, or liver
  • Abnormal complete blood count results
  • Newly diagnosed Acute Lymphoblastic Leukemia cases
  • Patients requiring treatment response monitoring
  • Individuals with family history of hematological malignancies

Significant Benefits of Genetic Testing

Choosing our ALL PCR Panel Cytogenetics test provides multiple advantages:

  • Precise Diagnosis: Accurate identification of specific genetic abnormalities for targeted treatment planning
  • Prognostic Information: Valuable insights into disease aggressiveness and expected treatment response
  • Treatment Monitoring: Essential tool for tracking minimal residual disease and treatment effectiveness
  • Personalized Medicine: Enables development of customized treatment strategies based on genetic profile
  • Early Detection: Facilitates timely intervention and improved clinical outcomes
  • Comprehensive Analysis: Multiple genetic markers assessed in a single, efficient test

Understanding Your Test Results

Your genetic test results will provide detailed information about the presence or absence of specific chromosomal abnormalities:

  • Positive Results: Indicate the presence of specific genetic rearrangements, guiding targeted therapy selection
  • Negative Results: Suggest absence of tested abnormalities, potentially indicating different leukemia subtypes
  • Quantitative Data: Real-Time PCR provides precise measurement of genetic abnormality levels for monitoring
  • Clinical Correlation: Results should be interpreted by hematologists in context of complete clinical picture
  • Treatment Implications: Specific genetic findings may influence chemotherapy choices and intensity

Test Specifications and Pricing

Test Parameter Details
Test Name ALL PCR Panel Cytogenetics – BCR/ABL, TEL/AML1, MLL, E2A
Discount Price $276 USD
Regular Price $376 USD
Turnaround Time 5-6 Days
Sample Type Bone Marrow / Peripheral Blood (Transport Immediately)
Test Components EDTA Vacutainer (2ml)
Testing Method Real-Time PCR
Specialty General Physician

Pre-Test Instructions and Requirements

The ALL PCR Panel (BCR/ABL, TEL/AML1, MLL, E2A) requires a Doctor’s prescription for testing. Please note that prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel. Our trained phlebotomists will collect the appropriate samples following standardized protocols to ensure optimal test accuracy.

Nationwide Accessibility

We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our nationwide network ensures accessible, reliable genetic testing services for patients throughout the country.

Take Control of Your Health Today

Don’t wait to get the critical genetic information you need for proper leukemia diagnosis and management. Our ALL PCR Panel Cytogenetics test provides the comprehensive genetic analysis required for informed medical decisions and personalized treatment approaches.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your appointment or book your test online. Our genetic specialists are ready to assist you with expert guidance and support throughout your testing journey.